• Aucun résultat trouvé

Aggressive Non-Hodgkin's Lymphoma

Serum selenium in lymphoma.

Serum selenium in lymphoma.

... in Lymphoma TO THE EDITOR: We read with interest the paper by Last et al 1 in a recent issue of Journal of Clinical ...with aggressive non-Hodgkin’s lymphoma ...

1

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma

... in non-Hodgkin’s lymphoma patients with high international prognostic index ...risk aggressive non-Hodgkin’s lymphoma: Final analysis of the prospective LNH87-2 protocol—A Groupe ...

8

The therapeutic effectiveness of 177Lu-lilotomab in B-cell non- Hodgkin lymphoma involves modulation of G2/M cell cycle arrest

The therapeutic effectiveness of 177Lu-lilotomab in B-cell non- Hodgkin lymphoma involves modulation of G2/M cell cycle arrest

... Conclusion We showed that 177 Lu-lilotomab is more ef ficient than rituximab in transformed FL preclinical models. 177 Lu- lilotomab is also ef ficient in BL cells (more aggressive NHL sub-type), but much higher ...

15

Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study

Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study

... Hodgkin’s Lymphoma Study Group and Lymphoma Work- ing Party of the European Group for Blood and Marrow Transplantation (2002) Aggressive con- ventional chemotherapy compared with high- dose ...

9

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas

... of lymphoma [ 14 ], suggesting that these malignant B-cells remain addicted to the BCR signalling induction by the ...of aggressive B- NHL supports a possible benefice of viral eradication also in this ...

11

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study

... for lymphoma before therapy with DAAs. We treated 3 patients with aggressive DLBCL concomitantly with polychemother- apy for lymphoma, and we observed a very rapid virologic ...

17

Calcium Independent Effect of Orai1 and STIM1 in Non-Hodgkin B Cell Lymphoma Dissemination

Calcium Independent Effect of Orai1 and STIM1 in Non-Hodgkin B Cell Lymphoma Dissemination

... lymphocyte; lymphoma 1. Introduction Diffuse large B cell lymphoma (DLBCL) is the most common and one of the most aggressive types of non-Hodgkin lymphoma among ...

18

Constitutive AKT activation in follicular lymphoma.

Constitutive AKT activation in follicular lymphoma.

... Follicular lymphoma is the most frequent occurring form of low grade of Non Hodgkin lymphoma (NHL) and account for approximately 20% of NHL cases ...into aggressive diffuse large B cell ...

10

Early F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab

Early F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab

... Our study demonstrates that ePET/CT 1 could guide the management of HL patients treated with anti PD-1 mAb. These results can be added to the recent advances in knowledge regarding precision medicine approaches guided by ...

27

Telomere Dysfunction And Chromosomal Instability In Hodgkin Lymphoma

Telomere Dysfunction And Chromosomal Instability In Hodgkin Lymphoma

... cell lymphoma patients (Camacho et al 2002, M'Kacher et al 2003a, M'Kacher et al 2003b, Schaffner et al 2000, Stilgenbauer et al ...more aggressive clinical course of the ...

258

Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study

Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study

... predominant Hodgkin lymphoma (NLPHL) is a rare entity distinct from classical Hodgkin lym- phoma (cHL), both in terms of histopathological features and clinical ...into aggressive ...

9

Richter syndrome with plasmablastic lymphoma

Richter syndrome with plasmablastic lymphoma

... Richter syndrome is a rare transformation of chronic lymphocytic leukemia into aggressive lymphoma. It occurs in 2% to 10% of cases. Most commonly, Richter syndromes harbor features of diffuse large B-cell ...

1

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.

... distinguish lymphoma types To investigate basal phosphorylation levels across B-NHL, we included patient samples from DLBCL, FL, MCL and CLL (Supplemental Table 1), as well as samples from healthy donors (tonsils ...

31

Aggressive landing maneuvers for unmanned aerial vehicles

Aggressive landing maneuvers for unmanned aerial vehicles

... In this thesis, we have presented a novel approach. to nonlinear vehicle trajectory tracking, when the important vehicle outputs change as a function of its state [r] ...

70

Traitement par brentuximab-bendamustine dans la maladie de Hodgkin : une étude rétrospective en vie réelle

Traitement par brentuximab-bendamustine dans la maladie de Hodgkin : une étude rétrospective en vie réelle

... DE HODGKIN : UNE ETUDE RETROSPECTIVE EN VIE REELLE INTRODUCTION Le lymphome de Hodgkin (LH) est une maladie peu fréquente de pronostique variable en fonction de la réponse au traitement ...

48

Total immunotherapy for Hodgkin lymphoma

Total immunotherapy for Hodgkin lymphoma

... L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ...

5

Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000).

Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000).

... networks and application of the advances in centres specializing in the treatment of childhood cancers (5). The aim of this study was to describe the survival of children aged less than 15 years presenting with acute ...

20

Long non-coding RNAs as molecular signatures for canine B-Cell lymphoma characterization

Long non-coding RNAs as molecular signatures for canine B-Cell lymphoma characterization

... B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in ...long non-coding RNAs (lncRNAs) play a key role in ...

12

The expression of genetic risk for aggressive and non-aggressive antisocial behavior is moderated by peer group norms

The expression of genetic risk for aggressive and non-aggressive antisocial behavior is moderated by peer group norms

... literature: aggressive and non-aggressive. Aggressive antisocial behavior refers to behaviors such as aggression, personal violence, and destruction of property, whereas non- ...

45

CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe d'Etude des Lymphomes de I'Adulte

CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe d'Etude des Lymphomes de I'Adulte

... of lymphoma relapses in the CHOP plus radiotherapy ...limited-stage aggressive lymphoma received consolidative radiotherapy after eight cycles of CHOP; as in the study by Miller et al, 5 the study ...

6

Show all 8005 documents...

Sujets connexes